KLDO Kaleido Biosciences, Inc.

$0.00

Kaleido Biosciences, Inc. (KLDO) is expected to report earnings on October 5, 2026, before the market open.

Earnings Date
Oct 5
Monday · 7:30 AM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Kaleido Biosciences, Inc.

Kaleido Biosciences Inc. is a clinical-stage healthcare company. It focuses on leveraging the potential of the microbiome organ to treat disease and improve human health. The Company's product candidates are Microbiome Metabolic Therapies(TM), which are designed to modulate the metabolic output and profile of the microbiome by driving the function and distribution of the organ's existing microbes. Kaleido Biosciences Inc. is based in Lexington, Massachusetts.

Sector

Healthcare

Charts powered in part by Lightweight Charts™ by TradingView.